Remove 2019 Remove Access Remove Epilepsy
article thumbnail

NORML Chapter Newsletter – April 2019

NORML

NORML Announces Plans for 2019 Conference and Lobby Day. David Phipps, communications director of Indiana Norml, said CBD oil can help with epilepsy, noting cases where some child patients went from over 100 seizures a day to near zero when they started taking CBD.” ” Read more from NORML.org !

article thumbnail

The Latin American Cannabis Landscape – Part Two: Regulated Markets and Patient Access

CannaTech

This statistic accounts for medicines treating patients with epilepsy, anxiety, depression, chronic pain, and other illnesses. Legal access does not necessarily equate to financial access. Although there is growing access to cannabis medicines, there is an increasing need for credible research and educational platforms.

Access 89
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Virginia, Marijuana, and How Medical Legalization May Unfold in the South

NORML

While patients won’t be rolling up joints full of pungent flower, they can still access oils, tinctures, lozenges, inhalers, topicals, and pills packed with non-intoxicating CBD or THC-A, the acidic precursor of THC. These were moms and dads and grandparents of children [with intractable epilepsy] who were using medical cannabis oils.

Marijuana 226
article thumbnail

CBD Market Report

Project CBD

Sales appear to have peaked in 2019, when natural channel consumers spent more than $90.7 Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022.

CBD 144
article thumbnail

Weekly Legislative Roundup 5/24/19

NORML

Legislation that would have significantly expanded patient access to medical cannabis in Rhode Island was held in a senate committee for further study, ultimately killing the bill. Legislation is pending, Senate Bill 236, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis.

article thumbnail

GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex

Cannabis Law Report

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. Accessed August 2021. 2019 Mar; 4(1): 73–84.

article thumbnail

Georgia Medical Cannabis Patients Can Now Purchase Cannabis Oil From Pharmacies

Veriheal

Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. Eligible patients were granted access to low-THC marijuana oil. In 2019, Georgia’s General Assembly passed Georgia’s Hope Act, which legalized the regulated cultivation of marijuana in the State.

Oil 98